ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Cardiac septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
4,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
12,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
13,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
13,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
14,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
16,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
18,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
19,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
19,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
21,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
24,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
28,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
29,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
30,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
30,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
31,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
31,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
32,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
32,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
33,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
35,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
35,4,Skin maceration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
